Document is current
Any future updates will be listed below
-
Authors
Terheyden, Jan Henrik https://orcid.org/0000-0002-0174-4066
Dunbar, Hannah M. P.
Schmitz-Valckenberg, Steffen
Behning, Charlotte
Martinho, Cecília
Luhmann, Ulrich F. O. https://orcid.org/0000-0002-1993-1951
Saßmannshausen, Marlene
Lüning, Anna
Miliu, Alexandra
Aires, Inês Dinis
Basile, Pier Giorgio
Batuca, Joana
Schmid, Matthias
Moll, Klaus-Peter
Zakaria, Nadia
Tufail, Adnan https://orcid.org/0000-0001-6131-7640
Binns, Alison
Crabb, David P. https://orcid.org/0000-0001-8754-3902
Leal, Sergio
Finger, Robert P.
Holz, Frank G. https://orcid.org/0000-0001-8019-9272
,
Agostini, H.
Aires, I. D.
Altay, L.
Atia, R.
Bandello, F.
Basile, P. G.
Batuca, J.
Behning, C.
Belmouhand, M.
Berger, M.
Binns, A.
Boon, C. J. F.
Böttger, M.
Brazier, J. E.
Carapezzi, C.
Carlton, J.
Carneiro, A.
Charil, A.
Coimbra, R.
Cosette, D.
Cozzi, M.
Crabb, D. P.
Cunha-Vaz, J.
Dahlke, C.
Dunbar, H.
Finger, R. P.
Fletcher, E.
Gutfleisch, M.
Hartgers, F.
Higgins, B.
Hildebrandt, J.
Höck, E.
Hogg, R.
Holz, F. G.
Hoyng, C. B.
Kilani, A.
Krätzschmar, J.
Kühlewein, L.
Larsen, M.
Leal, S.
Lechanteur, Y. T. E.
Lu, D.
Luhmann, U. F. O.
Lüning, A.
Manivannan, N.
Marques, I.
Martinho, C.
Miliu, A.
Moll, K. P.
Mulyukov, Z.
Paques, M.
Parodi, B.
Parravano, M.
Penas, S.
Peters, T.
Peto, T.
Priglinger, S.
Ramamirtham, R.
Ribeiro, R.
Rowen, D.
Rubin, G. S.
Sahel, J.
Sánchez, C.
Sander, O.
Saßmannshausen, M.
Schmid, M.
Schmitz-Valckenberg, S.
Siedlecki, J.
Silva, R.
Souied, E.
Staurenghi, G.
Tavares, J.
Taylor, D. J.
Terheyden, J. H.
Tufail, A.
Valmaggia, P.
Varano, M.
Wolf, A.
Zakaria, N.
-
Funding
Funding for this research was provided by:
Innovative Medicines Initiative (116076)
Innovative Medicines Initiative (116076)
Innovative Medicines Initiative (116076)
Innovative Medicines Initiative (116076)
Innovative Medicines Initiative (116076)
Innovative Medicines Initiative (116076)
Innovative Medicines Initiative (116076)
Innovative Medicines Initiative (116076)
Innovative Medicines Initiative (116076)
Innovative Medicines Initiative (116076)
- License Information
-
More Information
Article History
Received: 13 June 2024
Revised: 8 December 2024
Accepted: 17 December 2024
First Online: 5 February 2025
Competing interests
: Jan Henrik Terheyden: Heidelberg Engineering, Optos, Zeiss, CenterVue (now iCare), Novartis, Okko. Hannah M. P. Dunbar: Boehringer Ingelheim. Steffen Schmitz-Valckenberg: AlphaRET, Apellis, Bayer, Carl Zeiss Meditec, eyeDNA, Formycon, Galimedix, Heidelberg Engineering, Katairo, Kubota Vision, Novartis, Perceivve Therapeutics, Pixium, Roche, Sparing Vision. Charlotte Behning: None. Cecília Martinho: None. Ulrich F.O. Luhmann: Employee of and financial interest in F. Hoffmann-La Roche Ltd. Marlene Saßmannshausen: Heidelberg Engineering, Optos, Zeiss. Anna Lüning: None. Alexandra Miliu: None. Inês Aires: None. Pier Basile: None. Joana Batuca: None. Matthias Schmid: Pixum Vision. Klaus-Peter Moll: Employee of Novartis. Nadia Zakaria: Employee of Novartis. Adnan Tufail: Allergan, Bayer, Kanghong, Heidelberg Engineering, Novartis, Roche/Genentech, Iveric Bio, Apellis, Theá. Alison Binns: Apparatus and method for retinal measurement; Patent number 9492081; Boehringer-Ingelheim. David P. Crabb: Apellis, Santen, Allergan/Abbvie, Janssen; Thea. Sergio Leal: Employee of Bayer Pharma AG. Robert P. Finger: Alimera, Apellis, Bayer, Boehringer-Ingelheim, Novartis, ODOS, Oxford Innovation, ProGenerika, Roche/Genentech, Biogen, Icare, Heidelberg Engineering, Carl Zeiss Meditec. Frank G. Holz: Allergan, Annexon, Alzheon, Apellis, Astellas, Bayer, Boehringer-Ingelheim, Bioeq/Formycon, CenterVue (now iCare), Roche/Genentech, 4D Molecular Therapeuticcs, Geuder, Grayburg, Heidelberg Engineering, IvericBio/Astellas, Janssen, LinBiosciences, NightStarX, Novartis, Optos, Oxurion, Pixium Vision, Stealth BioTherapeutics, Carl Zeiss Meditec, Grade Reading Center.
